Deuramil
ActiveSummary
The computed 12-month bankruptcy probability of Deuramil is 1.7% (moderate). The 2025 annual accounts show equity of €22,584 and a net result of €18,584. Its solvency ranks better than 95% of 655 sector peers (NACE 16, financial year 2025). The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
2026
29-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
13-01
Gazette deed
IncorporationAppointment: URAZBAEV Ramil Rafaelevich (director) · Shareholding · Capital7 facts ▸
Gazette deed
Incorporation
Appointment: URAZBAEV Ramil Rafaelevich (director) · Shareholding · Capital7 facts ▸
- Shareholding, “aandeelhouder” (deed in Dutch)
- Capital
- Founding capital, €4,000
- Board rule, 1, “vergadering” (deed in Dutch)
- Director appointment, URAZBAEV Ramil Rafaelevich (director (not named in the articles))
- Registered office clause, “8520 Kuurne, Korianderplein 13 bus 0.1” (deed in Dutch)
- Pre-incorporation commitments, “takeover, all commitments and obligations arising therefrom, and all activities undertaken by the comparant in the name and for the account of the company in fo…” (deed in Dutch)
Gazette deedNBB filing
1 of 1 deed read